These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 25748532)

  • 21. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening.
    Rana P; Anson B; Engle S; Will Y
    Toxicol Sci; 2012 Nov; 130(1):117-31. PubMed ID: 22843568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Heart Cardiomyocytes in Drug Discovery and Research: New Opportunities in Translational Sciences.
    Abi-Gerges N; Miller PE; Ghetti A
    Curr Pharm Biotechnol; 2020; 21(9):787-806. PubMed ID: 31820682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Embryonic and Induced Pluripotent Stem Cell Based Toxicity Testing Models: Future Applications in New Drug Discovery.
    Shinde V; Sureshkumar P; Sotiriadou I; Hescheler J; Sachinidis A
    Curr Med Chem; 2016; 23(30):3495-3509. PubMed ID: 27356535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing.
    Ye L; Ni X; Zhao ZA; Lei W; Hu S
    J Cardiovasc Transl Res; 2018 Oct; 11(5):366-374. PubMed ID: 29845439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Content Assay Multiplexing for Vascular Toxicity Screening in Induced Pluripotent Stem Cell-Derived Endothelial Cells and Human Umbilical Vein Endothelial Cells.
    Iwata Y; Klaren WD; Lebakken CS; Grimm FA; Rusyn I
    Assay Drug Dev Technol; 2017; 15(6):267-279. PubMed ID: 28771372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
    Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High content screening for modulators of cardiac differentiation in human pluripotent stem cells.
    Spiering S; Davidovics H; Bushway PJ; Mercola M; Willems E
    Methods Mol Biol; 2015; 1263():43-61. PubMed ID: 25618335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types.
    Doherty KR; Talbert DR; Trusk PB; Moran DM; Shell SA; Bacus S
    Toxicol Appl Pharmacol; 2015 May; 285(1):51-60. PubMed ID: 25841593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling.
    Abaci HE; Shuler ML
    Integr Biol (Camb); 2015 Apr; 7(4):383-91. PubMed ID: 25739725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip.
    Li Z; Guo Y; Yu Y; Xu C; Xu H; Qin J
    Integr Biol (Camb); 2016 Oct; 8(10):1022-1029. PubMed ID: 27605158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy.
    Carlson C; Koonce C; Aoyama N; Einhorn S; Fiene S; Thompson A; Swanson B; Anson B; Kattman S
    J Biomol Screen; 2013 Dec; 18(10):1203-11. PubMed ID: 24071917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approach to Neurotoxicity using Human iPSC Neurons: Consortium for Safety Assessment using Human iPS Cells.
    Shirakawa T; Suzuki I
    Curr Pharm Biotechnol; 2020; 21(9):780-786. PubMed ID: 31782362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A microfluidic dual gradient generator for conducting cell-based drug combination assays.
    Kilinc D; Schwab J; Rampini S; Ikpekha OW; Thampi A; Blasiak A; Li P; Schwamborn R; Kolch W; Matallanas D; Lee GU
    Integr Biol (Camb); 2016 Jan; 8(1):39-49. PubMed ID: 26569638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization.
    Burnett SD; Blanchette AD; Chiu WA; Rusyn I
    Expert Opin Drug Metab Toxicol; 2021 Aug; 17(8):887-902. PubMed ID: 33612039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Embryonic stem cells as a novel cell source of cell-based biosensors.
    Liu Q; Huang H; Cai H; Xu Y; Li Y; Li R; Wang P
    Biosens Bioelectron; 2007 Jan; 22(6):810-5. PubMed ID: 16621504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes.
    Guo L; Abrams RM; Babiarz JE; Cohen JD; Kameoka S; Sanders MJ; Chiao E; Kolaja KL
    Toxicol Sci; 2011 Sep; 123(1):281-9. PubMed ID: 21693436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microcavity array (MCA)-based biosensor chip for functional drug screening of 3D tissue models.
    Kloss D; Kurz R; Jahnke HG; Fischer M; Rothermel A; Anderegg U; Simon JC; Robitzki AA
    Biosens Bioelectron; 2008 May; 23(10):1473-80. PubMed ID: 18289841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
    Ting S; Chen A; Reuveny S; Oh S
    Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional innervation of human induced pluripotent stem cell-derived cardiomyocytes by co-culture with sympathetic neurons developed using a microtunnel technique.
    Sakai K; Shimba K; Ishizuka K; Yang Z; Oiwa K; Takeuchi A; Kotani K; Jimbo Y
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):138-143. PubMed ID: 29042197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiomyocytes derived from human embryonic stem cells - characteristics and utility for drug discovery.
    Steel D; Hyllner J; Sartipy P
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):133-40. PubMed ID: 19152222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.